CBD Oil Cause Acid Reflux

CBDISTILLERY

Buy CBD Oil Online

Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far The endocannabinoid system (ECS) primarily consists of cannabinoid receptors (CBRs), endogenous ligands, and enzymes We will be focusing on something that more people turn to when those symptoms hit from acid reflux or GERD, which is CBD. CBD for Acid Reflux has been found to be effective as per recent research. Using CBD oil for acid reflux helps alleviate symptoms like pain and inflammation.

Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far

The endocannabinoid system (ECS) primarily consists of cannabinoid receptors (CBRs), endogenous ligands, and enzymes for endocannabinoid biosynthesis and inactivation. Although the presence of CBRs, both CB1 and CB2, as well as a third receptor (G-protein receptor 55 [GPR55]), has been established in the gastrointestinal (GI) tract, few studies have focused on the role of cannabinoids on esophageal function. To date, studies have shown their effect on GI motility, inflammation and immunity, intestinal and gastric acid secretion, nociception and emesis pathways, and appetite control. Given the varying and sometimes limited efficacy of current medical therapies for diseases of the esophagus, further understanding and investigation into the interplay of the ECS on esophageal health and disease may present new therapeutic modalities that may help advance current treatment options. In this brief review, the current understanding of the ECS role in various esophageal functions and disorders is presented.

Overview of Endocannabinoid System

The endocannabinoid system (ECS) primarily consists of cannabinoid receptors (CBRs), endogenous ligands, and enzymes for endocannabinoid biosynthesis and inactivation. 1 The ECS plays an important role in regulation of synaptic transmission in the central and enteric nervous systems (ENS) through both excitatory and inhibitory effects, mediating a variety of physiological processes including pain sensation and modulation, motor function, inflammation, and immunity. 2

CBRs belong to the superfamily of G-protein-coupled receptors and are expressed in two main forms, CB1 and CB2. 3 CB1 is mainly expressed in central and peripheral neurons, including the ENS, whereas CB2 is mostly expressed by inflammatory/immune cells. 4–6 The ubiquitous distribution of CBRs in the ENS and gastrointestinal (GI) tract highlights its role in GI health and disease including motility, inflammation and immunity, intestinal and gastric acid secretion, nociception and emesis pathways, and appetite control 7–9 ( Table 1 ).

The CB1 receptor plays a role in intestinal motility by attenuating both large and small bowel muscle tone when activated. 10–13 Within the upper GI tract, activation of CB1 decreases intragastric pressure and delays gastric emptying through inhibition of excitatory neurons. 14,15 As demonstrated in rodent models, CB1 receptors play a role in energy regulation by driving consumption of food high in dietary fat. 16 After sham feeding in rats with high-fat foods, upregulation of CB1 receptors was found in rat small intestine, leading to inhibition of neural signaling events of satiety to suppress feeding. These findings suggest that CB1 acts through a positive feedback loop after dietary fat exposure to stimulate further consumption of higher energy foods. In another study, pharmacological inhibition of CB1 led to decreased amount of refeeding in rats after food deprivation, highlighting CB1 receptor’s role in appetite regulation. 17 In addition, CB1 was found to be upregulated in rats fed a high fat, high caloric Western diet (WD). It was also suggested to play a role in hyperphagia after antagonism of CB1 with an inhibitor led to decreased food intake in rats fed a WD for 60 days. 18

CB2 receptors located in the central nervous system (CNS) have been shown to play a role in the emetic pathway; however, the receptor has also been found in inflammatory tissue and immune cells (plasma cells and macrophages) throughout the GI tract. 19–22 CB2 is expressed in the GI tract but less extensively than CB1 receptors. 23 Evidence that upregulation of CB2 receptors occurs in patients with inflammatory bowel disease suggests that these receptors play a critical role in colonic inflammation. 7 Distinct from CB1 receptors effect on motility, CB2 receptors may further regulate motility in pathophysiological states with its expression being upregulated in inflammatory disease states. 5,24

Presence of CBRs in human esophageal epithelium was first demonstrated in a study comparing patients with nonerosive esophageal reflux disease (NERD) and erosive esophageal reflux disease (ERD) to normal controls. 25 The authors found increased expression of CB1 mRNA in NERD patients compared with erosive esophagitis, but overall less expression compared with normal controls. Interestingly, CB1 protein expression was similar to patients with ERD, whereas NERD patients showed increased CB1 receptor levels when compared with healthy controls ( Fig. 1 ). Although other GI inflammatory conditions have increased CB1 activity, there may be contribution of the inflammatory microenvironment that alters CB1 gene expression. 24

Immunostaining of CB1 receptor in histological sections of esophageal mucosa. Healthy subjects (a) show a weak positive staining localized in mature squamous cells (black arrow) and in connectival papillae (red arrows). NERD patients (b) show CB1 receptor .

Recently, a potential third CBR has been identified with implications in the GI tract. G-protein receptor 55 (GPR55) shares 13–15% sequence homology with the CB1 and CB2 receptors and responds to a multitude of endogenous and exogenous cannabinoid ligands as well as several lipids. 26 A recent study found activation of GPR55 after administration of a synthetic agonist slowed down whole-gut transit in mice in vivo, suggesting GPR55 may be involved in the regulation of gut motility. 27

Endocannabinoids are endogenously produced ligands that exert effects on CBRs. The major ligands, anandamide (AEA) and 2-arachidonylglycerol (2-AG), play a role in maintaining GI homeostasis and have been found at increased levels in GI disease states, including celiac disease, diverticulosis, and colorectal cancer. 28–30 Exogenous cannabinoids, both plant-derived phytocannabinoids (cannabis sativa) and synthetic cannabinoids, also directly activate CBRs. They have been shown to play a role in both GI pathophysiology (e.g., cannabinoid hyperemesis syndrome) and therapies (e.g., antiemetics and appetite stimulant). 31

Although both CB1 and CB2 receptors have been found in the esophagus, few studies have focused on the role of cannabinoids on esophageal function. 21 Thus far, the role of GPR55 in esophageal motility has not been established. Given the varying and sometimes limited efficacy of current medical therapies for diseases of the esophagus, further understanding and investigation into the interplay of the ECS on esophageal health and disease may present new therapeutic modalities that may help advance current treatment options. In this review, the current understanding of the role of ECS in various esophageal functions and disorders is presented.

Swallowing Mechanism

The swallowing reflex is an important mechanism in controlling acid exposure in the esophagus, whereby increased swallowing decreases stasis and reduces acidic and nonacidic reflux. The role of the swallowing reflex in reducing reflux has been demonstrated after observation that supine sleeping patients experienced a decreased spontaneous swallowing reflex during 24-h pH monitoring, leading to increased acid and nonacid exposure. 32 CB1 receptor activation has been shown to decrease spontaneous swallows in human and animal studies. One study on dogs found administration of CB1 agonist suppressed spontaneous swallowing in a dose-dependent manner with an >80% decrease in spontaneous swallows at high doses (57 nmol/kg). 33 The authors noted that although administration of CB1 agonist decreased transient lower esophageal sphincter relaxations (TLESRs) thereby decreasing reflux events, the concomitant decrease in spontaneous swallows and clearance of refluxate potentially limit the benefits of decreasing TLESRs. The mechanism of action of CBRs on swallowing mechanism is likely centrally located through endogenous cannabinoid action, modifying synaptic neurotransmitter release. 34 The swallowing reflex, evoked by repetitive electrical stimulation of the superior laryngeal nerve in rats, was analyzed with and without combinations of both CB1 and CB2 agonists and antagonists. CB1 receptor antagonist injected directly into the nuclear tractus solitarius blocked the action of intravenous-administered CB1 agonist. The only study in humans to date found administration of the combination CB1/CB2 agonist Δ9-THC resulted in a significant reduction in the number of swallows wherein high doses (20 mg) led to a reduction in spontaneous swallows by 50%. 35

Esophageal Motility

CBRs, specifically CB1, play a role in GI motility and have mainly been studied in the small intestine and colon. 8,10 Only two studies have evaluated the effect of ECS on esophageal motility in humans. 35,36 Administration of Δ9-THC decreased basal lower esophageal sphincter (LES) pressure in a nondose-dependent manner, with onset occurring 45 min after meal ingestion, maximal effect around 100 min, followed by slow recovery. 35 This was confirmed in another human study that administration of rimonabant, a CB1 receptor antagonist, increased postprandial LES pressures in the first and second postprandial hours. 36

See also  CBD Oil Meaning In English

Previous studies in animal models did not demonstrate CBR action influenced esophageal motility. Lehman et al. demonstrated that CBR agonism did not influence the extent of LES relaxation. Similarly, CBR antagonists had no influence on esophageal peristalsis. 33 A recent case report suggested that exogenous phytocannabinoid use improved symptoms of dysphagia in a patient with manometric findings, consistent with type 3 achalasia. 37 Others have suggested that exogenous cannabinoid use, like chronic opiate use, may produce motor findings similar to type 3 achalasia. 38 The conflicting data support the need for further study of endo- and exogenous cannabinoids on esophageal motility. 39

Gastroesophageal Reflux Disease and TLESRs

TLESRs are the predominant mechanism seen in gastroesophageal reflux disease (GERD). TLESRs occur after gastric stimuli, mainly distension, to relieve counteracting gastric pressure on the LES. 40,41 The LES response to gastric distension is vagally mediated through communication of the LES and crural diaphragm with afferent gastric pathways, brainstem integrative centers (nucleas tractus solitarus and dorsal motor nucleus), and efferent inhibitory pathways. 41 The action of CBRs on TLESRs and GERD was first demonstrated in animal models after the observation that administration of a CB1 agonist (WIN55,212-2) reduced the rate of TLESRs without altering the TLESRs latency or esophageal peristalsis. 33 The authors concluded that the action of the CBRs on TLESRs most likely occured via central pathways because no effect on the extent of LES relaxation was seen. 33,42,43 Absence of CB1 receptors in preganglionic vagal motor neurons projecting to the gastric fundus or LES further supports the assumption that CB1 does not directly participate in vagal motor output modulation and rather relies on central activation. 42

Interestingly, the use of a CB1 receptor antagonist (rimonabant) in healthy human subjects enhanced postprandial LES pressure but unexpectedly decreased TLESRs. 36 This contradicts earlier data in an animal model with dogs that showed rimonabant enhanced the rate of TLESRs and reflux events that received acidified meal and intragastric air insufflation. 36 The authors attributed this discrepancy to different dosage, bioavailability, or interspecies differences of rimonabant. A possible explanation for the similar results from administrating CBR antagonist and agonists may be a result of rimonabant exerting potent CB1 receptor-independent pharmacological effects. 44

Gastric accommodation may affect TLESRs and play an important role in development of GERD. 45 Previous studies evaluated the effect of CB1 receptors on pain sensation during intragastric balloon distension, however, they did not find modulation of CB1 receptors with rimonabant-influenced mechanosensitivity of the proximal stomach. 46 It should be noted that baclofen has been shown to decrease TLESRs rate and increase basal LES pressure while not affecting meal-induced fundic accommodation, suggesting that the mechanism may not be as simple as binary, an observation previously suggested by Lehmann et al. 33 Other studies have suggested that using Δ9-THC inhibits gastric insufflation-induced LES relaxations in the decerebrate ferret, highlighting the need for further clarification of the relationship between gastric stimulation and TLESRs. 10

The effect of CBRs on gastric emptying has been studied in humans although the data are limited and conflicting. 48–51 Although there may be some influence of CBRs, gastric emptying itself does not necessarily correlate with fundus accommodation and activation of TLESRs.

The presence of CBRs in the esophagus, specifically those affecting TLESRs, offers a potential therapeutic target for treating GERD. Using Δ9-THC, Beaumont et al. demonstrated decreased rate of TLESRs in healthy volunteers who received 10 and 20 mg of Δ9-THC on three occasions a week apart. 35 Delta(9)-THC significantly reduced the number of TLESRs and caused a nonsignificant reduction of acid reflux episodes in the first postprandial hour. In addition, lower esophageal sphincter pressure and swallowing were significantly reduced by Δ(9)-THC. 35 However, in the high dose of Δ9-THC (20 mg) group, central activity led to increased nausea and vomiting. Centrally acting CB1 receptor agonists produce the psychotropic effects and, therefore, selective targeting of peripheral CB1 receptors is necessary for effective therapy, with recent efforts to develop higher potency and effective CB1 agonists. 52,53 Previous studies have looked at using CB1 antagonists; however, their therapeutic use is also limited by its side effect of major depression. 54

Newer methodologies for understanding the pharmacodynamics and pharmacokinetics of medication effects on TLESRs have been developed that may provide more accurate modeling of drug concentrations and their effects. 55

Bronchoconstriction

In patients with a chronic cough where lung disease, environmental exposure, and medications have been excluded, GERD is often a major cause. 56 The two main mechanisms implicated in reflux-related cough are microaspiration of refluxate and stimulation of vagal innervation of the esophagus, leading to esophagobronchial reflex arc. The CB2 receptor has been shown to play a role in inhibiting bronchoconstriction and microvascular leakage in reflux models using guinea pigs. After infusion of intraesophageal HCl, the inhibitory effect of bronchoconstriction by a CB1 agonist (WIN55,212-2) was blocked after administration of a CB2 antagonist (SR 144528) but not after CB1 receptor antagonist, demonstrating CB2 receptor’s role as a downregulatory mechanism of sensory nerve activation. 57 CB2 receptor activation in models of direct airway damage has been shown to play an active role in reducing inflammation, potentially supporting protective role of CB2 in microaspiration of refluxate. 58

Visceral Hypersensitivity and Pain

Functional esophageal disorders are defined as the presence of esophageal symptoms in the absence of structural, inflammatory, or motor abnormalities. 59 Proposed pathophysiological mechanisms include alterations in neural processing between peripheral triggers and central perception of esophageal symptoms. 60 CBRs likely play a role in pain sensation and modulation through visceral antinociceptive action. 61 Previous studies have demonstrated an analgesic effect of cannabinoids in animal models through both CB1 and CB2 activation. 62–64 In one important study, upregulation of the endocannabinoid AEA through inhibition of its degrading enzyme led to an attenuated behavioral response to noxious stimuli in rodents. 65 This suggests a central role of CB1 receptors in mitigating pain-related inputs to the CNS.

There are few studies of visceral sensitivity in the esophagus and the effects of CBR modulation. In a randomized, placebo controlled trial, administration of dronabinol for 1 month increased the threshold for first sensation, pain frequency, and intensity of pain during an esophageal balloon distention test. 66 Notably, anxiety and depression indices were unchanged after dronabinol administration. The mainstay of functional esophageal disorders relies on tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin norepinephrine reuptake inhibitors, all of which have been found to influence psychiatric parameters, highlighting a possible difference in mechanism of action. 60

Role in Esophageal Neoplasm

Cannabinoids inhibit tumor cell growth and induce apoptosis by modulating cell signaling pathways. 67 Decreased frequency of CNR-1 gene, the gene encoding CB1 receptor, expression was found in tissue of esophageal cancer patients (10.8%) compared with controls (60.0%), and its presence is considered an independent predictor of survival. 68 However, recently a multivariate analysis revealed that CB1 receptor overexpression was independently associated with poor prognosis (p=0.019). Biological analysis of CB1 receptor overexpression using esophageal squamous carcinoma cell lines revealed that CB1 receptor activation appeared to promote cell proliferation and invasion. 69 Thus, the role of CB1 receptor expression in tumorogenesis needs to be further evaluated.

Conclusion

A more thorough understanding of the ECS in esophageal function and disease is needed. Recently, there has been a push to legalize cannabis for both medicinal and recreational use. There have also been reports of increasing use of both plant-derived cannabis and synthetic cannabinoids in the United States. 70 This may allow additional studies to be added to the few human studies to date on the effect of cannabinoid use in humans. Further study in this area is imperative for the development of future therapeutic potential of utilizing the ECS.

Authors’ Contributions

J.G. was involved in literature review and is the primary author. R.K. was involved in literature review. R.S. was involved in study conceptualization and reviewed the article.

What Can CBD Do for People Suffering from Acid Reflux or GERD?

Lots of us get heartburn from time to time, and while it often has to do with something that we ate or eating too fast, sometimes it can be indicative of a more systemic issue such as acid reflux or GERD. Commonly confused with one another, these two distinctive conditions both cause frequent heartburn that can interfere with a person’s quality of life by causing potentially severe pain, especially after eating.

Both of these conditions, thankfully, are treatable and can be managed by making certain adjustments to one’s diet and habits in many instances. Another potential approach could be done in a holistic way with cannabidiol (CBD), a hemp-derived compound that has certainly been getting a lot of attention lately for its many uses and lots of research behind it.

See also  1500 Mg CBD Oil

So, can CBD help with the symptoms associated with acid reflux and GERD? Read on to find out.

What is Acid Reflux?

Acid reflux is a condition that’s more common than GERD, and is localized to the upper digestive tract, pertaining to the esophagus, diaphragm, and stomach. Those who have acid reflux experience stomach acid flowing up into the esophagus, and due to the acidic nature of the substance, it can cause a burning sensation. Acid reflux typically intensifies shortly after a person eats, as well as when they lie down, which can interfere with the flow of the upper digestive system.

Symptoms of Acid Reflux

Acid reflux is associated with a few different symptoms, and everyone’s case will be unique, which means that a person with acid reflux may have only one of the symptoms below or multiple symptoms:

  • Heartburn and pain in the chest
  • Difficult swallowing food or saliva
  • Loss of appetite
  • Regurgitation after eating
  • An acidic taste in the mouth
  • A feeling of having a lump in one’s throat

Why Does Acid Reflux Occur?

There are many reasons why a person may develop acid reflux, including poor dietary choices and the habit of lying down after eating, or even eating too fast. Smokers and those who consume too much alcohol are more prone to the condition, and certain medications can make the development of acid reflux more likely.

The most common cause of acid reflux is a hiatal hernia, which allows for the stomach to move above the diaphragm, bringing the upper digestive tract out of alignment which enables digestive acids to flow easily from the stomach and into the esophagus. The diaphragm plays a large role in keeping acid inside of the stomach, so if it’s misaligned, this can lead to acid reflux.

It’s also worth noting that pregnant women may develop acid reflux as the fetus puts pressure on the upper digestive tract, and this can be temporary or last after the baby is born.

What is Gastroesophageal Reflux Disease? (GERD (Gastroesophageal Reflux Disease)

Gastroesophageal reflux disease is a severe form of acid reflux. It simply means that a person has acid reflux episodes at least once a week. GERD is associated with potential complications as the constant flow of stomach acid into the esophagus can lead to corrosion from its high acidic content.

What are GERD’s Symptoms?

The symptoms of GERD are the same as those of acid reflux, including heartburn, difficulty swallowing and pain that intensifies when lying down. For a person to have GERD, they must have a severe episode at least once a week, or a moderate episode at least twice a week, for over a month.

Why Does GERD Occur?

As of now, it is not exactly clear why some instances of acid reflux develop into GERD and some do not. The most likely theory is that prolonged acid reflux episodes cause the lower esophageal sphincter to weaken. This sphincter is supposed to loosen when a person is eating and tighten when they are not eating. If the sphincter becomes weak, it can never properly close, which can make it easy for stomach acid to pass through and into the esophagus.

How are Acid Reflux and GERD Treated?

A person who is experiencing frequent heartburn or other symptoms described above should schedule an appointment with a specialist as soon as possible. In rare cases, these symptoms can be associated with something more serious such as a heart condition or cancer within the digestive tract. Only a trained gastroenterologist can diagnose you and prescribe treatments. Typically, an endoscopy is performed to determine the cause of the issue.

Both of these conditions are typically treated with medication. Usually, the patient is given antacids that neutralize the stomach acid. For more severe cases, H2 blockers may be prescribed which decrease levels of stomach acid, and this is reserved for more serious cases because lowering stomach acid levels can interfere with other digestive functions over time.

There is a surgical procedure that is pretty new to the medical world, which is the installation of a LINX device into the lower esophageal sphincter. This is a metal ring that makes up for the weakened state of the sphincter so that stomach acid cannot flow as easily through the sphincter and reach the esophagus.

Using CBD for Acid Reflux and GERD

CBD is a cannabinoid and it’s also a unique type of compound only found in the cannabis genus. Cannabinoids are fed to cannabinoid receptors found in all systems of the body, including the digestive system, which creates a chemical reaction that allows for regulation of individual bodily processes. The cannabinoid receptors in the body make up the endocannabinoid system that ultimately has the job of keeping the body in a state of homeostasis.

Studies show that cannabinoid receptors in the esophagus and stomach may utilize cannabinoids to regulate the function of the esophageal sphincter and regulate the flow and neutralization of stomach acid. By attaching to these receptors, CBD may help offer relief to symptoms caused by acid reflux by creating an environment in which stomach acid is less likely to enter the esophagus.

How to Use CBD Properly for These Conditions

Because there is enough research showing that cannabidiol may play a role in managing acid reflux, we can cover the proper methods for using it to get the best results possible. With an array of products on the market, and many methods for taking it, this information can make a big difference when it comes to finding relief.

Talk with Your Medical Healthcare Provider and a Specialist

You must see a specialist about your condition, and during this time, you can ask them about using CBD for potential relief. It is important that you discuss medications you are taking, as some medications may interact with cannabidiol due to suppression of the CYP3A4 enzyme that must be abundant in the body to break down specific types of drugs.

Use an Oral Form of CBD

We suggest using an oral form of CBD such as a tincture or an edible, which maintains direct contact with the upper digestive system to truly interact with the cannabinoid receptors that are involved in functions pertaining to acid reflux and GERD. If you can, take these products daily to manage symptoms as best as possible.

A Potential Holistic Method For Treating Acid Reflux or GERD Has Arrived!

Both acid reflux and GERD can cause enormous discomfort and make us dread eating our favorite meals. If you’re dealing with heartburn, it is important to get a diagnosis and consider starting a routine with CBD. This gentle and natural product is becoming immensely popular among sufferers of these conditions now that medical researchers are discovering what it can do for our body’s digestion.

CBD for Acid Reflux and GERD – Is It Effective?

If you are reading this post, you (or someone you know) likely experience a burning sensation in the chest or throat, especially after eating spicy food.

You have tried the traditional treatments of acid reflux or GERD and have not seen the expected results. It’s also possible you have heard about the benefits of CBD use and are wondering whether it can help with your acid reflux symptoms.

Luckily you have found this post. Here we look at everything you need to know about CBD for acid reflux and GERD. We will also learn how using CBD oil for acid reflux provides relief from its symptoms.

Let’s get started:

Table of Contents

How is Acid Reflux Caused? Is CBD for Acid Reflux Beneficial?

The gastrointestinal system is a sensitive organ in your body. When your digestive network is interfered with, it may lead to acid reflux (the acid stomach backflow).

Acid reflux happens when the stomach acid moves into your esophagus when the lower esophageal sphincter (LES), which is supposed to close when food passes through, fails to close or opens more often.

As such, the acid produced by your stomach moves up into the esophagus leading to unpleasant symptoms, including:

  • Heartburn (burning chest discomfort)
  • Regurgitation
  • Dysphagia
  • Bloating
  • Burping
  • Nausea
  • Hiccups
  • Dry cough, wheezing, or hoarseness

Drinking coffee, taking a hearty meal, or alcohol consumption can cause heartburn in people with acid reflux. Many people commonly experience acid reflux in the morning that causes lots of discomforts.

See also  Zebra CBD Oil

What’s the Difference Between Acid Reflux and GERD?

Although acid reflux and gastroesophageal disease are related, the terms mean different things.

As earlier stated, acid reflux happens when stomach acid flows back into the esophagus resulting in heartburn. Usually, this occurs after taking spicy meals or drinking coffee or alcohol.

GERD occurs when you have a more severe form of reflux with symptoms of severe acid reflux . Heartburn is the most common symptom of GERD (more than two times a week). Other GERD symptoms include difficulty swallowing, chest pain. Regurgitation of sour liquid, and coughing.

As you can see, acid reflux and GERD exhibit the same symptoms, but the symptoms occur more than twice a week in people with GERD.

CBD Reflux Benefits – Demand in the Global Market

As of 2019, the global cannabis legal market was valued at 17.7 billion U.S. dollars. It is expected that the market will be worth 73.6 billion U.S. dollars by 2027.

Gerd and Marijuana health benefits and the continued legalization in various countries are the major drivers of this vast market.

We have seen the emergence of many CBD brands to cater to the increasing cannabis demand. If you plan to invest in the CBD industry, it is imperative to work with a reputable CBD marketing agency .

The best CBD marketing agency understands the industry trends and will use their expertise to put your business before your target market without being at loggerheads with authorities.

CBD for Acid Reflux and GERD

Before we look at the benefits of CBD for GERD , let’s take a closer look at the Endocannabinoid System (ECS) and its role in our bodies.

The ECS plays a vital role in your wellbeing and regulates many biological functions including, sensations, memory, anti-secretory effects, and pain perception.

Cannabinoids (found in the cannabis plant and those found in the body) play a vital role in gastric and intestinal acid secretion and regulate gastrointestinal motility.

CBD reacts with the endocannabinoid system and may reduce the acid secretion that causes heartburn in GERD patients.

CBD and ECS will prevent or reduce the severity of GERD by reducing inflammation and mucosal damage. Besides, it may help lower esophageal relaxation.

CBD for Pain Management

Pain is a common problem for GERD patients. CBD is known to activate CB1 and CB2 cannabinoid receptors to produce analgesic effects that help relieve pain, including pain from the gastrointestinal tract.

Compared to conventional pain medications, CBD oil for pain relief is a safer alternative for acid reflux patients. Many people suffering from acid reflux are aware of CBD and pain management benefits and are using CBD to derive its positive health benefits.

People with GERD experience pain in the chest, throat, or stomach. Certain pain medications can make GERD worse. They include:

This is where marijuana comes in. CBD can help reduce pain, meaning you do not have to take pain medications that can worsen GERD. Marijuana is better than medicine for acid reflux and will alleviate pain without irritating your stomach and esophagus.

Cannabis for acid reflux Relieves Stomach Acid

Although clinical trials on the effects of cannabis on stomach acid secretion are yet to be conducted, some preclinical studies suggest that cannabinoids may help inhibit gastric acid production.

In a study involving rats, cannabinoids were found to reduce stress-induced ulcers. That being the case, researchers believe that cannabis may help inhibit gastric acid secretion in humans.

Some cannabinoids are known to protect the stomach lining, meaning cannabis may be useful for GERD patients. So CBD can be one of the best acid reflux natural remedies for people chronically suffering from GERD.

Marijuana for GERD Reduces Inflammation

Is CBD good for GERD ? Although more research is required to determine if marijuana is a useful option for treating GERD, available studies suggest that cannabis may help boost endocannabinoid’s ability to reduce inflammation.

In turn, this might help combat GERD symptoms and repair mucosal damage. CBD also binds to cannabinoid receptors in the gastrointestinal system to prevent peristalsis (involuntary muscle movements), thus reducing the chances of the stomach acid going back into the esophagus.

CBD Decreases Stress

Can stress cause acid reflux ? Yes, stress and anxiety are known to trigger GERD symptoms. Luckily, medical cannabis may help you feel less anxious and overwhelmed. In the end, this might reduce stress-related ailments like stomach pain and nausea.

Your mental health is closely related to gastrointestinal health (GI). Conversely, stress and GERD are linked.

Taking medical marijuana may help calm your mind. However, talk to your doctor about the right dosage, as taking a higher THC dose can hurt you.

What’s the Best Way to Take CBD for Acid Reflux?

Having that you have read to this point, it’s likely you want to try CBD for GERD and are wondering how to take it. Here’s how to take CBD for acid reflux :

CBD Oil for Acid Reflux Benefits

To get the best benefits of CBD for acid reflux , you should know about CBD oil for GERD dosage . As the name suggests, CBD oil comes in a liquid form. Taking CBD oil for acid reflux is straightforward – measure an appropriate dose using a glass dropper and place it under the tongue.

Hold it in your mouth for about one minute before swallowing it. You will start feeling the effects of CBD oil within fifteen to thirty minutes of use and last up to six hours.

CBD Vapes – Best Medicine for Acid Reflux

If you are looking for the fastest and effective way of taking CBD for GERD , vaping is the way to go. Vaping has the highest bioavailability than tinctures and oral CBD products, as it gets into the bloodstream within three to five minutes of inhalation.

However, compared to CBD oils, CBD vape effects last for a few hours, meaning it might not be the best option if you need long-lasting effects from GERD symptoms.

CBD Capsules – For Heartburn and Acid Reflux Relief

CBD capsules may be ideal for you if you want to take CBD on the go. CBD capsules offer a discreet way to use CBD in your workplace.

However, taking CBD for acid reflux or GERD in the form of capsules will have a slower onset (between 40 and 90 minutes) than CBD oils and vapes. CBD capsules need to pass through your digestive system to feel the effect.

CBD Edibles and Acid Reflux Benefits

CBD edibles come in different flavors, making it a more enjoyable way to take CBD. However, when taking CBD gummies for GERD, keep in mind that the effects delay as they will have to pass through the liver.

How much CBD to Take for Acid Reflux?

Since the FDA does not control many CBD products, there is no standard recommendation of CBD dosage for acid reflux.

The right CBD dosage for you will depend on various factors, including:

  • Gender
  • Age
  • Weight
  • The severity of the symptoms
  • Unique body chemistry
  • Prior CBD experience

As a rule of thumb, start small (about 1 – 6 mg of CBD for every 10 pounds) and increase slowly until you get your ideal dosage. Keep a record of how each dose affects your GERD symptoms.

If taken in the right dosage, CBD is the best medicine for acid reflux and can relieve your symptoms to a great extent.

CBD for Acid Reflux Side Effects

As with any other medication, cannabis use may have side effects. Talk to your doctor about the best CBD/THC levels for you and the best method of use to reduce the risk of side effects.

Depending on the cannabis strain that you take, dose, and your CBD experience , you may experience any of the following side effects:

  • Dry mouth
  • Insomnia
  • Fatigue
  • Diarrhea
  • Red eyes
  • Paranoia
  • Drowsiness
  • Constipation
  • Dizziness
  • Impaired balance

So, Should You Take CBD for Acid Reflux ?

Although much research is needed, CBD has been shown to help with acid reflux and GERD. Marijuana interacts with the endocannabinoid system to soften the gastrointestinal muscles and protect the lining from damage.

That way, it leads to improved peristalsis, thus preventing stomach content’s backflow in the esophagus .

Talk to your doctor before taking CBD for acid reflux or GERD, especially if you take other medications.

How useful was this post?

Click on a star to rate it!

Average rating 3 / 5. Vote count: 1

No votes so far! Be the first to rate this post.